Page last updated: 2024-09-05

hmr 1766 and Blood Clot

hmr 1766 has been researched along with Blood Clot in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauersachs, J; Eigenthaler, M; Ertl, G; Flierl, U; Kobsar, A; Schäfer, A	1

Other Studies

1 other study(ies) available for hmr 1766 and Blood Clot

Article	Year
Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats. Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:12 Topics: Animals; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Activation; Enzyme Activators; Guanylate Cyclase; Male; Microfilament Proteins; Nitric Oxide; ortho-Aminobenzoates; Phosphoproteins; Platelet Activation; Platelet Aggregation; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Sulfonamides; Thrombosis	2006

Article

Year

Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.

Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:12

Topics: Animals; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Activation; Enzyme Activators; Guanylate Cyclase; Male; Microfilament Proteins; Nitric Oxide; ortho-Aminobenzoates; Phosphoproteins; Platelet Activation; Platelet Aggregation; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Sulfonamides; Thrombosis

2006